相关实验视频
Updated: Jun 11, 2025

05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
28.5K
创伤性脑损伤加剧酒精消费和神经炎症,认知和胆固醇活性下降
bioRxiv : the preprint server for biology
|October 10, 2024
概括
创伤性脑损伤 (TBI) 在小鼠中增加了酒精消费和认知缺陷,通过激活微质细胞和减少胆固醇神经元. 削弱的微质被保护免受这些TBI影响,这表明了新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 创伤性脑损伤研究研究
- 滥用酒精 研究 研究 研究 滥用酒精
背景情况:
- 创伤性脑损伤 (TBI) 是全球死亡和残疾的主要原因.
- 显著的百分比的TBI患者在他们的系统中存在酒精,TBI是滥用酒精的危险因素.
- 关联TBI和酒精消费的确切机制尚不清楚.
研究的目的:
- 在小鼠模型中调查TBI对酒精消费和认知功能的影响.
- 探索细胞机制,特别是微质和胆性内神经元 (CINs) 在TBI诱导的变化中的作用.
- 评估微质枯竭的神经保护潜力.
主要方法:
- 利用流体打击伤害 (FPI) 模型在小鼠中诱导TBI.
- 评估酒精消费和认知表现.
- 检查了纹状体中的细胞变化,重点关注微质和胆固醇内部神经元群体.
- 研究了微质衰竭对神经保护和胆固醇功能的影响.
主要成果:
- 在小鼠中,FPI显著增加了酒精消费和认知功能受损.
- 创伤导致条状胆神经内神经元 (CIN) 和它们的活动减少.
- FPI增加了状体中微质细胞的数量.
- 耗尽微质细胞减轻了TBI诱导的胆固醇损失,并增强了胆固醇活性.
结论:
- 脑损伤促进酒精消费和认知缺陷,可能是通过微质激活和随后降低胆固醇功能.
- 微质在与酒精使用相关的TBI的神经生物学后果中发挥着关键作用.
- 向微质激活可能为患有酒精使用问题的TBI患者提供一种新的治疗策略.
相关概念视频
CNS Depressants: Alcohol and Nicotine
178
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
178
Role of Neurotransmitters in Memory
458
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
458
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449

